{"id":121205,"date":"2025-05-29T22:24:35","date_gmt":"2025-05-29T15:24:35","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=121205"},"modified":"2025-07-24T13:13:22","modified_gmt":"2025-07-24T06:13:22","slug":"lenvimon-4","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/lenvimon-4\/","title":{"rendered":"LENVIMON – 4"},"content":{"rendered":"
Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n thu\u1ed1c LENVIMON – 4 \u0111\u01b0\u1ee3c \u0111\u0103ng k\u00fd b\u1edfi Prospera Life Sciences private limited \u0111\u01b0\u1ee3c \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam <\/strong><\/p>\n Trong m\u1ed7i LENVIMON – 4 c\u00f3 ch\u1ee9a: Lenvatinib 4mg<\/p>\n D\u1ea1ng b\u00e0o ch\u1ebf: Vi\u00ean nang<\/p>\n S\u0110K: \u0110ang c\u1eadp nh\u1eadt<\/p>\n Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 30 vi\u00ean<\/p>\n Xu\u1ea5t x\u1ee9: \u1ea4n \u0110\u1ed9<\/p>\n H\u1ea1n s\u1eed d\u1ee5ng: Xem tr\u00ean bao b\u00ec<\/p>\n Lenvatinib l\u00e0 m\u1ed9t ch\u1ea5t \u1ee9c ch\u1ebf tyrosine kinase \u0111a m\u1ee5c ti\u00eau, \u1ee9c ch\u1ebf c\u00e1c th\u1ee5 th\u1ec3 VEGFR1-3, FGFR1-4, PDGFR\u03b1, KIT v\u00e0 RET. Qua vi\u1ec7c ch\u1eb7n c\u00e1c t\u00edn hi\u1ec7u n\u00e0y, thu\u1ed1c l\u00e0m gi\u1ea3m s\u1ef1 ph\u00e1t tri\u1ec3n m\u1ea1ch m\u00e1u nu\u00f4i kh\u1ed1i u, k\u00ecm h\u00e3m t\u0103ng sinh t\u1ebf b\u00e0o ung th\u01b0, t\u1eeb \u0111\u00f3 \u1ee9c ch\u1ebf s\u1ef1 ti\u1ebfn tri\u1ec3n c\u1ee7a b\u1ec7nh. Lenvatinib c\u00f2n th\u1ec3 hi\u1ec7n hi\u1ec7u qu\u1ea3 ch\u1ed1ng kh\u1ed1i u m\u1ea1nh h\u01a1n khi ph\u1ed1i h\u1ee3p v\u1edbi thu\u1ed1c mi\u1ec5n d\u1ecbch (kh\u00e1ng PD-1) ho\u1eb7c everolimus (\u1ee9c ch\u1ebf mTOR).<\/p>\n LENVIMON – 4 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng cho ng\u01b0\u1eddi l\u1edbn m\u1eafc ung th\u01b0 tuy\u1ebfn gi\u00e1p bi\u1ec7t h\u00f3a ti\u1ebfn tri\u1ec3n, t\u00e1i ph\u00e1t t\u1ea1i ch\u1ed7 ho\u1eb7c \u0111\u00e3 di c\u0103n, kh\u00f4ng c\u00f2n \u0111\u00e1p \u1ee9ng v\u1edbi \u0111i\u1ec1u tr\u1ecb b\u1eb1ng iod ph\u00f3ng x\u1ea1.<\/p>\n \u0110i\u1ec1u tr\u1ecb ban \u0111\u1ea7u: Ph\u1ed1i h\u1ee3p lenvatinib v\u1edbi pembrolizumab gi\u00fap ki\u1ec3m so\u00e1t RCC ti\u1ebfn tri\u1ec3n \u1edf ng\u01b0\u1eddi l\u1edbn ch\u01b0a t\u1eebng \u0111i\u1ec1u tr\u1ecb tr\u01b0\u1edbc \u0111\u00f3.<\/p>\n Sau \u0111i\u1ec1u tr\u1ecb kh\u00e1ng sinh m\u1ea1ch: D\u00f9ng ph\u1ed1i h\u1ee3p lenvatinib v\u1edbi everolimus cho b\u1ec7nh nh\u00e2n RCC ti\u1ebfn tri\u1ec3n \u0111\u00e3 qua \u00edt nh\u1ea5t m\u1ed9t li\u1ec7u tr\u00ecnh \u0111i\u1ec1u tr\u1ecb ch\u1ed1ng h\u00ecnh th\u00e0nh m\u1ea1ch.<\/p>\n LENVIMON – 4 l\u00e0 l\u1ef1a ch\u1ecdn kh\u1edfi \u0111\u1ea7u cho ng\u01b0\u1eddi b\u1ec7nh b\u1ecb HCC kh\u00f4ng c\u00f2n ch\u1ec9 \u0111\u1ecbnh ph\u1eabu thu\u1eadt tri\u1ec7t c\u0103n.<\/p>\n Ph\u1ed1i h\u1ee3p LENVIMON – 4 v\u00e0 pembrolizumab \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh cho ng\u01b0\u1eddi l\u1edbn m\u1eafc ung th\u01b0 n\u1ed9i m\u1ea1c t\u1eed cung ti\u1ebfn tri\u1ec3n, c\u00f3 ki\u1ec3u gen pMMR v\u00e0 kh\u00f4ng thu\u1ed9c nh\u00f3m MSI-H, \u0111\u00e3 th\u1ea5t b\u1ea1i v\u1edbi h\u00f3a tr\u1ecb to\u00e0n th\u00e2n tr\u01b0\u1edbc \u0111\u00f3 v\u00e0 kh\u00f4ng ph\u00f9 h\u1ee3p cho \u0111i\u1ec1u tr\u1ecb tri\u1ec7t c\u0103n b\u1eb1ng ph\u1eabu thu\u1eadt ho\u1eb7c x\u1ea1 tr\u1ecb.<\/p>\n Li\u1ec1u khuy\u1ebfn c\u00e1o: 24 mg u\u1ed1ng m\u1ed7i ng\u00e0y, duy tr\u00ec \u0111\u1ebfn khi b\u1ec7nh ti\u1ebfn tri\u1ec3n ho\u1eb7c x\u1ea3y ra \u0111\u1ed9c t\u00ednh kh\u00f4ng th\u1ec3 ki\u1ec3m so\u00e1t.<\/p>\n Ch\u01b0a \u0111i\u1ec1u tr\u1ecb tr\u01b0\u1edbc \u0111\u00f3: 20 mg lenvatinib m\u1ed7i ng\u00e0y + pembrolizumab 200 mg ti\u00eam truy\u1ec1n t\u0129nh m\u1ea1ch m\u1ed7i 3 tu\u1ea7n.<\/p>\n \u0110\u00e3 \u0111i\u1ec1u tr\u1ecb tr\u01b0\u1edbc: 18 mg lenvatinib + 5 mg everolimus u\u1ed1ng m\u1ed7i ng\u00e0y.<\/p>\n Li\u1ec1u t\u00f9y theo c\u00e2n n\u1eb7ng:<\/p>\n \u226560 kg: 12 mg\/ng\u00e0y<\/p>\n <60 kg: 8 mg\/ng\u00e0y<\/p>\n 20 mg lenvatinib\/ng\u00e0y + pembrolizumab 200 mg truy\u1ec1n t\u0129nh m\u1ea1ch m\u1ed7i 3 tu\u1ea7n.<\/p>\n D\u00f9ng m\u1ed7i ng\u00e0y m\u1ed9t l\u1ea7n, v\u00e0o th\u1eddi \u0111i\u1ec3m c\u1ed1 \u0111\u1ecbnh, kh\u00f4ng ph\u1ee5 thu\u1ed9c v\u00e0o b\u1eefa \u0103n.<\/p>\n N\u1ebfu b\u1ecf l\u1ee1 li\u1ec1u v\u00e0 ch\u01b0a qu\u00e1 12 gi\u1edd, u\u1ed1ng b\u1ed5 sung ngay. N\u1ebfu qu\u00e1 12 gi\u1edd, b\u1ecf qua li\u1ec1u \u0111\u00f3.<\/p>\n Ng\u01b0\u1eddi d\u1ecb \u1ee9ng v\u1edbi Lenvatinib v\u00e0 nh\u1eefng t\u00e1 d\u01b0\u1ee3c c\u00f3 trong LENVIMON – 4<\/p>\n LENVIMON – 4 c\u00f3 kh\u1ea3 n\u0103ng k\u00e9o d\u00e0i kho\u1ea3ng QT. C\u1ea7n tr\u00e1nh ph\u1ed1i h\u1ee3p v\u1edbi c\u00e1c thu\u1ed1c c\u0169ng g\u00e2y k\u00e9o d\u00e0i QT ho\u1eb7c l\u00e0m r\u1ed1i lo\u1ea1n \u0111i\u1ec7n gi\u1ea3i.<\/p>\n Hi\u1ec7n ch\u01b0a c\u00f3 b\u00e1o c\u00e1o hay nghi\u00ean c\u1ee9u v\u1ec1 m\u1ee9c \u0111\u1ed9 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn s\u1ef1 t\u1eadp trung do \u0111\u00f3 nh\u1eefng ng\u01b0\u1eddi \u0111i\u1ec1u khi\u1ec3n ph\u01b0\u01a1ng ti\u1ec7n giao th\u00f4ng v\u00e0 m\u00e1y m\u00f3c c\u1ea7n l\u01b0u \u00fd theo d\u00f5i tri\u1ec7u ch\u1ee9ng g\u1eb7p ph\u1ea3i khi d\u00f9ng thu\u1ed1c tr\u01b0\u1edbc khi tham gia c\u00e1c ho\u1ea1t \u0111\u1ed9ng n\u00e0y \u0111\u1ec3 \u0111\u1ea3m b\u1ea3o \u0111\u1ed9 an to\u00e0n.<\/p>\n N\u1ebfu th\u1ea5y m\u1ec7t m\u1ecfi th\u00ec d\u1eebng ngay c\u00e1c ho\u1ea1t \u0111\u1ed9ng n\u00e0y l\u1ea1i<\/p>\n Lenvatinib c\u00f3 \u00e1i l\u1ef1c cao v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng, do \u0111\u00f3 kh\u00f4ng lo\u1ea1i b\u1ecf hi\u1ec7u qu\u1ea3 b\u1eb1ng l\u1ecdc m\u00e1u. Qu\u00e1 li\u1ec1u c\u00f3 th\u1ec3 g\u00e2y t\u1eed vong do suy \u0111a c\u01a1 quan.<\/p>\n LENVIMON – 4 hi\u1ec7n \u0111ang \u0111\u01b0\u1ee3c b\u00e1n t\u1ea1i nhi\u1ec1u nh\u00e0 thu\u1ed1c tr\u00ean to\u00e0n qu\u1ed1c v\u1edbi gi\u00e1 dao \u0111\u1ed9ng kh\u00e1c nhau nh\u01b0ng kh\u00f4ng qu\u00e1 nhi\u1ec1u. Ch\u00fang t\u00f4i s\u1ebd th\u01b0\u1eddng xuy\u00ean c\u1eadp nh\u1eadt m\u1ee9c gi\u00e1 ngay \u0111\u1ea7u trang \u0111\u1ec3 b\u1ea1n \u0111\u1ecdc tham kh\u1ea3o.<\/p>\n Tr\u01b0\u1eddng h\u1ee3p LENVIMON – 4 t\u1ea1m th\u1eddi h\u1ebft h\u00e0ng, qu\u00fd kh\u00e1ch c\u00f3 th\u1ec3 tham kh\u1ea3o c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c c\u1ee7a nh\u00e0 thu\u1ed1c c\u00f3 c\u00f9ng ho\u1ea1t ch\u1ea5t v\u00e0 t\u00e1c d\u1ee5ng v\u1edbi LENVIMON – 4 nh\u01b0:<\/p>\n Nexavar 200mg<\/a> c\u00f3 th\u00e0nh ph\u1ea7n l\u00e0 Lenvatinib h\u00e0m l\u01b0\u1ee3ng 10mg, \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Everest Pharmaceuticals \u2013 Bangladesh, c\u00f3 t\u00e1c d\u1ee5ng \u0111i\u1ec1u tr\u1ecb c\u00e1c lo\u1ea1i ung th\u01b0 nh\u01b0 gan, th\u1eadn, tuy\u1ebfn gi\u00e1p<\/p>\nLENVIMON – 4 l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n
Th\u00e0nh ph\u1ea7n<\/h3>\n
Tr\u00ecnh b\u00e0y<\/h3>\n
T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c LENVIMON – 4<\/h2>\n
C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n
\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n
\n
Thu\u1ed1c LENVIMON – 4 \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n
\n
\n
\n
\n

Li\u1ec1u d\u00f9ng v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng<\/h2>\n
Li\u1ec1u d\u00f9ng<\/h3>\n
\n
\n
\n
\n
C\u00e1ch s\u1eed d\u1ee5ng<\/h3>\n
Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c LENVIMON – 4 trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/h2>\n
L\u01b0u \u00fd \u0111\u1eb7c bi\u1ec7t khi s\u1eed d\u1ee5ng thu\u1ed1c<\/h2>\n
Th\u1eadn tr\u1ecdng<\/h3>\n
\n
T\u00e1c d\u1ee5ng ph\u1ee5<\/h3>\n
\n
T\u01b0\u01a1ng t\u00e1c<\/h3>\n
L\u01b0u \u00fd cho ph\u1ee5 n\u1eef c\u00f3 thai v\u00e0 cho con b\u00fa<\/h3>\n
\n
L\u01b0u \u00fd khi s\u1eed d\u1ee5ng cho ng\u01b0\u1eddi l\u00e1i xe v\u00e0 v\u1eadn h\u00e0nh m\u00e1y m\u00f3c<\/h3>\n
Qu\u00e1 li\u1ec1u v\u00e0 x\u1eed tr\u00ed<\/h3>\n
B\u1ea3o qu\u1ea3n<\/h3>\n
\n
Thu\u1ed1c LENVIMON – 4 gi\u00e1 bao nhi\u00eau? b\u00e1n \u1edf \u0111\u00e2u?<\/h2>\n